Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Capital Employed: 2019-2025

Historic Return on Capital Employed for Bicycle Therapeutics (BCYC) over the last 6 years, with Sep 2025 value amounting to -0.40%.

  • Bicycle Therapeutics' Return on Capital Employed fell 20.00% to -0.40% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.40%, marking a year-over-year decrease of 20.00%. This contributed to the annual value of -0.30% for FY2024, which is 14.00% up from last year.
  • Latest data reveals that Bicycle Therapeutics reported Return on Capital Employed of -0.40% as of Q3 2025, which was down 7.75% from -0.37% recorded in Q2 2025.
  • Over the past 5 years, Bicycle Therapeutics' Return on Capital Employed peaked at -0.18% during Q1 2022, and registered a low of -0.40% during Q3 2025.
  • Moreover, its 3-year median value for Return on Capital Employed was -0.35% (2023), whereas its average is -0.32%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first increased by 17bps in 2021, then fell by 20bps in 2025.
  • Over the past 5 years, Bicycle Therapeutics' Return on Capital Employed (Quarterly) stood at -0.19% in 2021, then decreased by 13bps to -0.32% in 2022, then declined by 2bps to -0.35% in 2023, then rose by 12bps to -0.23% in 2024, then dropped by 20bps to -0.40% in 2025.
  • Its Return on Capital Employed stands at -0.40% for Q3 2025, versus -0.37% for Q2 2025 and -0.29% for Q1 2025.